EUDA Health (EUDA) news
Recent news
Epiroc AB: Barclays raises target price to SEK 285 from SEK 280
Barclays has raised its target price for Epiroc AB (EPI.A) to SEK 285 from SEK 280, reflecting the firm’s confidence in the company’s operational performance and market positioning. The adjustment, while modest, underscores the analyst’s view of Epiroc’s strong fundamentals and continued growth in…
AInvest Wire · 1d agoTrading halted: (RDACU) Due to limit-up limit-down trading pause
On October 6, 2026, shares of RDACU were temporarily suspended from trading due to a limit-up limit-down pause, a mechanism designed to prevent excessive volatility in securities. This halt occurred as the stock approached price thresholds that triggered the pause, a common practice on exchanges…
AInvest Wire · Oct 6, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.